SIETES :: 93020 citas

Resultados de la búsqueda por ODONTOLOGÍA REFINAR BÚSQUEDA

1.

Anónimo. FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women. U.S. Food and Drug Administration 2019:21 de junio. [Ref.ID 103134]

2.

Schroeder AR, Dehghan M, Newman TB, Bentley JP, Park KT. Association of opioid prescriptions from dental clinicians for US adolescents and young adults with subsequent opioid use and abuse. JAMA Intern Med 2018:3 de diciembre. [Ref.ID 102858]

3.

Chen TT, Yeh YC, Chien KL, Lai MS, Tu YK. Risk of infective endocarditis after invasive dental treatments: a case-only study. Circulation 2018:19 de abril. [Ref.ID 102607]

4.

5.

Comunicado de prensa. American Dental Association announces new policy to combat opioid epidemic. Policy supports mandates on opioid prescribing and continuing education . American Dental Association 2018:26 de marzo. [Ref.ID 102482]

6.

Moore PA, Ziegler KM, Lipman RD, Aminoshariae A, Carrasco-Labra A, Mariotti A. Benefits and harms associated with analgesic medications used in the management of acute dental pain. The Journal of the American Dental Association 2018;149:abril. [Ref.ID 102481]

7.

Campaigno EP, Kebir I, Montastruc JL, Rueter M, Maret D, Lapeyre-Mestre M, Sallerin B, Despas F. Drug-induced dental caries: a disproportionality analysis using data from VigiBase. Drug Saf 2017;40:1249-58. [Ref.ID 102146]

8.

Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorenzton M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 2017:11 de septiembre. [Ref.ID 102052]

9.

de Boissieu P, Kanagaratnam L, Mahmoudi R, Morel A, Dramé M, Trenque T. Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review. Eur J Clin Pharmacol 2017;73:517-23. [Ref.ID 101992]

10.

Akram Z, Abduljabbar T, Kellesarian SV, Hassan MIA, Javed F, Vohra F. Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review. Br J Clin Pharmacol 2017;83:444-54. [Ref.ID 101463]

11.

Anónimo. Addendum: Doxycycline for young children? . The Medical Letter on Drug and Therapeutics Bulletin 2016;58:82. [Ref.ID 100419]

12.

Anónimo. Riesgo de osteonecrosis mandibular asociado a la administración de aflibercept (Zaltrap) . Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2016:16 de marzo. [Ref.ID 100031]

13.

Dear JW, Antoine DJ, Park BK. Where are we now with paracetamol?. BMJ 2015;351:h3705. [Ref.ID 99251]

14.

Bischoff-Ferrari HA, Meyer O. Comparative effectiveness of pharmacologic treatments to prevent fractures: is this all we need to know?. Ann Intern Med 2014;161:711-23. [Ref.ID 98329]

15.

Crandall CJ, Newberry SJ, Diamant A, Lim Y-W, Gellad WF, Booth MJ, Motala A, Shekelle PG. Comparative effectiveness of pharmacologic treatments to prevent fractures: and updated systematic review. Ann Intern Med 2014;161:711-23. [Ref.ID 98328]

16.

Anónimo. AINS: phlegmons, cellulites cervicales?. Prescrire 2014;34:516. [Ref.ID 98077]

17.

Anónimo. Denosumab: minimising the risk of osteonecrosis of the jaw; monitoring for hypocalcaemia - Updated recommendations. Drug Safety Update 2014;8:septiembre. [Ref.ID 98056]

18.

Chiu WY, Chien JY, Yang WS, Juanq JM, Lee JJ, Tsai KS. The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene.. J Clin Endocrinol Metab 2014;99:2729-35. [Ref.ID 97859]

19.

Moyer VA, on behalf of the US Preventive Services Task Force. Prevention of dental caries in children from birth through age 5 years. U.S. Preventive Services Task Force recommendation statement. Pediatrics 2014;133:1102-11. [Ref.ID 97543]

20.

Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, Sequist ER, Reddy MS, Lewis CE, Oates TW, Tripathy D, Katancik JA, Orlander PR, Paquette DW, Hanson NQ, Tsai MY. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial. JAMA 2013;310:2523-32. [Ref.ID 96673]